A phase 1, open ‐label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies

Cancer, EarlyView.

Source: Cancer - October 9, 2018 Category: Cancer & Oncology Authors: Christos Fountzilas, Milind Javle, Wei Tan, Yingyu Ma, Gerald Fetterly, Renuka Iyer, Candace Johnson Source Type: research